UNION CITY, Calif.,
April 19, 2011 /PRNewswire/ --
Abaxis, Inc. (NasdaqGS: ABAX), a medical products company
manufacturing point-of-care blood analysis systems, has scheduled a
conference call to discuss its financial results for the fourth
quarter and fiscal year 2011, ended March
31, 2011. The call will be at 4:15
p.m. ET on Thursday, April 28,
2011. The Company will report financial results for
the fourth quarter and fiscal year 2011 after the market closes on
Thursday, April 28, 2011.
Participants can dial (877) 317-6789 or (412) 317-6789 to access
the conference call, or can listen via a live Internet web cast,
which is available in the Investor Relations section of the
company's website at www.abaxis.com. A replay of the call is
available by visiting www.abaxis.com for the next 30 days or by
calling (877) 344-7529 or (412) 317-0088, confirmation code 450287,
through May 3, 2011.
About Abaxis
Abaxis develops, manufactures, markets and sells portable blood
analysis systems for use in any veterinary or human patient-care
setting to provide clinicians with rapid blood constituent
measurements. The system consists of a compact, 5.1 kilogram
(11.2 pounds), portable analyzer and a series of single-use plastic
discs, called reagent discs that contain all the chemicals required
to perform a panel of up to 13 tests on veterinary patients and 14
tests on human patients. The system can be operated with
minimal training and performs multiple routine tests on whole
blood, serum or plasma samples. The system provides test
results in less than 12 minutes with the precision and accuracy
equivalent to a clinical laboratory analyzer.
Contact:
|
Clint Severson
|
Lytham Partners, LLC
|
|
|
Chief Executive
Officer
|
Joe Dorame, Joe Diaz &
Robert Blum
|
|
|
Abaxis, Inc.
|
602-889-9700
|
|
|
510-675-6500
|
|
|
|
|
|
SOURCE Abaxis, Inc.